Meeting
2024 ASCO Gastrointestinal Cancers Symposium
PD1 and CD39 expression on tumor infiltrating lymphocytes in patients with gastric cancer.
Authors
Takafumi Okayama
National Cancer Center Hospital East, Kashiwa, Japan
Takafumi Okayama , Nobuo Tsukamoto , Toshihiro Suzuki , Kiyotaka Mochizuki , Junichi Sano , Hiromi Nagata , Daiki Terajima , Takumi Habu , Mitsumasa Yoshida , Kazuma Sato , Naoto Fujiwara , Masahiro Yura , Takeo Fujita , Manami Shimomura , Kazunobu Oonuki , Kyoko Fukuda , Yasushi Uemura , Tetsuya Nakatsura , Takahiro Kinoshita
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 377)
DOI
10.1200/JCO.2024.42.3_suppl.377
Abstract #
377
Poster Bd #
H19
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Evaluating the repertoire of immune checkpoint markers expressed on peripheral and ascites CD8+ T cells in ovarian cancer.
First Author: Stephanie Gaillard
Poster
2023 ASCO Annual Meeting
Effect of a novel expansion process on tumor-infiltrating lymphocyte (TIL) polyfunctionality, cytotoxicity, and expansion, while preserving cells in a less differentiated and more stem-like phenotype.
First Author: Andrew Yuhas
Poster
2018 ASCO Annual Meeting
Immune profiling in a randomized phase II trial of acalabrutinib and pembrolizumab (PA) versus pembrolizumab (P) for patients with metastatic urothelial cancer (mUC).
First Author: Tian Zhang
Poster
2016 ASCO Annual Meeting
Analysis of immune infiltrates in a genomically characterized clinical cohort of head and neck squamous cell carcinoma (HNSCC) patients (pts).
First Author: Nicole Grace Chau